Creo Medical Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Creo Medical Limited generated cash of -$21,600,000, which is more than the previous year. Cash used in financing activities reached the amount of $29,800,000 last year. Net change in cash is therefore -$10,100,000.
Cash Flow
| 2016 | -3.12M | -138.98K | 5.52M |
|---|---|---|---|
| 2018 | -6.99M | -825.93K | 501.60K |
| 2018 | -14.19M | -1.38M | 46.48M |
| 2019 | -11.54M | -1.11M | 49.11M |
| 2020 | -16.08M | -21.16M | 1.32M |
| 2021 | -25.98M | -7.87M | 31.99M |
| 2022 | -24.98M | -6.02M | 522K |
| 2023 | -21.6M | -18.3M | 29.8M |
CREO.L Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 13.1M | 43.53M | 45.09M | 81.04M | 44.58M | 13.68M | 13.68M | 305.24K |
Operating activities | ||||||||
Net income | -21.7M | -26.93M | -24.59M | -20.31M | -15.91M | -9.87M | -8.40M | -3.84M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 3.4M | 3.11M | 2.56M | 1.59M | 641.72K | 331.61K | 309.71K | 103.51K |
Stock-based compensation expense | 1.2M | 1.4M | 2.56M | 728K | 1.55M | 0 | 1.02M | 277.04K |
| Deferred income tax benefit | 1.2M | 1.4M | 2.56M | 728K | 1.55M | 0 | 1.02M | 277.04K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | -1.4M | -1.57M | -3.17M | -394K | -552.69K | -514.25K | 0 | -319.69K |
Inventories | -400K | -348K | -2.96M | 767K | -424.68K | -211.13K | 22.56K | 0 |
Accounts payable | -3.7M | -902K | 1.87M | 1.68M | 3.28M | 143.74K | 0 | 205.22K |
Cash generated by operating activities | -21.6M | -24.98M | -25.98M | -16.08M | -11.54M | -14.19M | -6.99M | -3.12M |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.2M | -3.27M | -6.12M | -576K | -1.11M | -1.38M | -846.09K | -145.78K |
Acquisitions Net | -2.4M | -2.75M | -1.75M | -20.58M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -18.3M | -6.02M | -7.87M | -21.16M | -1.11M | -1.38M | -825.93K | -138.98K |
Financing activities | ||||||||
Common Stock Issued | 31.7M | 70K | 34.20M | 159K | 49.30M | 46.06M | 528.43K | 5.52M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.50M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -26.82K | 0 |
Repayments of term debt | -1.9M | 1.27M | -1.7M | -1.55M | 0 | -418.26K | 0 | 0 |
Cash used in financing activities | 29.8M | 522K | 31.99M | 1.32M | 49.11M | 46.48M | 501.60K | 5.52M |
Net Change In Cash | -10.1M | -30.43M | -1.55M | -35.95M | 36.45M | 30.89M | -7.32M | 2.26M |
Cash at end of period | 3M | 13.09M | 43.53M | 45.09M | 81.04M | 44.58M | 6.36M | 2.56M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |